Oncoustics is revolutionizing point-of-care diagnostics with its patented AI solutions that transform inexpensive ultrasound devices into powerful tools for the rapid, non-invasive detection and monitoring of liver diseases. Their innovative approach leverages raw ultrasound signals to provide accurate diagnostics without the need for image interpretation, making it accessible for any clinician. With a focus on improving patient outcomes and experiences, Oncoustics offers a suite of applications that streamline the diagnostic process, reduce costs, and enhance productivity in clinical settings. The company has validated its technology through extensive clinical partnerships and is positioned in a $30B global diagnostic market, addressing a critical need for early detection of liver disease, which is the fastest-growing cause of death globally.
Something looks off?On-site & Remote